Displaying drugs 14776 - 14800 of 14838 in total
2-[1-METHYLHEXYL]-4,6-DINITROPHENOL
Experimental
ETC-1001
ETC-1001 is Pfizer’s lead oral small molecule product candidate which is intended to be a chronic treatment for individuals with lipid disorders.
Investigational
Denibulin
Denibulin is a novel small molecule Vascular Disrupting Agent under development by MediciNova for treatment of solid tumor cancers.
Investigational
P-Nitrophenol
Experimental
3-(4-nitrophenyl)-1H-pyrazole
Experimental
AL-4623
Experimental
1,8-Di-Hydroxy-4-Nitro-Anthraquinone
Experimental
AEOL-10150
AEOL 10150 is developed by Aeolus as a therapeutic agents based on its proprietary small molecule catalytic antioxidants.
Investigational
Displaying drugs 14776 - 14800 of 14838 in total